At the end of the day, ENZC needs funding to move its core products (ITV#/Clone#) into western trial phases.
Without a partnership or a buyout, the only way to do it is with a reverse split, dilution combo. This has a negative connotation, but it's how they can raise funds if they've been unable to bring in a third-party pharma company. And that's probably why ENZC has been holding back news/test results and isn't SEC reporting. The plan is to reduce the share count, release all the news, thus driving the price up, and then dilute enough to cover clinical trials.
A SPAC is an excellent opportunity for this. It allows the company to uplist to NASDAQ, reduce the share count, and it allows them to release their news, and issue new shares to raise funds.
I think the company failed to get a biotech partner in the last few years. Most good deals were probably awaiting some phase results. The plan was then to audit the company and uplist inside pinks. However, SAGA presented a way to uplist, reduce share county, allow dilution without shareholders losing holdings value, AND enrich ENZC management with extra shares.
And so ENZC ditched the plan to audit, sec report, and uplist on OTCQB in favor of SAGA's SPAC. From the released court papers, it seems that SAGA is the primary bad actor and ENZC's management did nothing illegal. (If communications between SAGA and ENZC come out and prove otherwise, we're in deep doo-doo) Nonetheless, ENZC's management looks incompetent at best and scumbags/scammers at worse.
Hopefully, we didn't turn down more legitimate fundraising avenues for SAGA. Especially considering all the free shares ENZC management was going to gain from the deal. I hope the company still has a path forward, but with the share price crash, audit and uplist are now off the table. And with this whole ordeal, hopefully, the company does not have a scarlet letter with other SPACs/investors.
Of course, we've only heard one side of the case. ENZC needs to put out a statement. If SAGA is dead (as it seems ) and another SPAC/Partner/Buyout is not in the cards, they need to audit and SEC report NOW. Hopefully there will be enough there to sure up the stock price and allow us to uplist. I have my doubts now. :(